Gene Query: HIST2H2BE

Dataset Description Geneva Score
Uridylation by TUT4 and TUT7 marks mRNA for degradation 130.62
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 114.67
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 98.87
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 92.21
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 91.69
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 91.69
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 89.77
Comparison of microRNA Profiling Platforms 84.42
Comparison of microRNA Profiling Platforms (HTS) 84.42
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 82.43
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 78.23
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 78.23
Impact of dieldrin on transcription in Jurkat T cells 73.24
Genome wide expression change in LCC2 and MCF-7 cells 71.86
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 66.39
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 66.39
LNCaP treated with iBET 64.04
Expression and functions of long noncoding RNAs during human T helper cell differentiation 62.29
Transcriptome analysis of Zika infected neural stem cells 61.77
Zika infected neural stem cells 61.77
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 60.65
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 59.29
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 58.79
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 58.14
RNA-seq of shEZH2 cells 56.95
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 52.72
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 52.72
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 51.82
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 51.82
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 50.16
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 47.85
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 47.16
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 44.61
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 44.6
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 44.41
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 43.79
Tracking distinct RNA populations using efficient and reversible covalent chemistry 43.47
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 43.01
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 42.88
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 41.61
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 41.61
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 41.47
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 40.8
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 39.59
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 39.49
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 38.39
Differential gene expression of human melanoma cells [RNA-seq] 38.19
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 38.19
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 38.02
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 37.94
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 37.51
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 37.32
Studying the selectivity of a small molecule Synucleozid on transcriptome 36.57
SRSF2 mutations impair hematopoiesis and alter exon recognition 36.17
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 36.14
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 35.99
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 35.41
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 35.24
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 35.19
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 35.19
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 34.8
RNA-sequencing in irradiated and normal A549 cells. 34.51
CD95/Fas ligand mRNA is toxic to cells 33.6
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 33.59
Endothelial gene expression analysis 33.38
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 33.38
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 32.66
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 32.66
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 32.31
Active translatome profiling with RiboLace in MCF7 cells 32.12
Cellular response to hepatitis E virus (HEV) infection 32.04
Primary human trophoblast from term placenta 31.84
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 31.66
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 31.44
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 31.1
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 31.02
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 30.18
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 30.18
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 29.49
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 29.4
Determination of tRNA aminoacylation levels by high throughput sequencing 29.08
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 28.59
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 28.58
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 28.21
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 28.08
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 27.63
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 27.35
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 27.24
Human neutrophil genome during PMA- and E. coli encounter-induced activation 26.97
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 26.97
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 26.6
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 26.6
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 25.7
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 25.54
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 25.54
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 25.45
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 25.17
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 25.17
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 24.99
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 24.8
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 24.74
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 24.58
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 24.51
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 24.06
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 24.03
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 24.03
U1 snRNP telescripting regulates size-function stratified human genome 24.03
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 23.78
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 23.2
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 22.98
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 22.98
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 22.73
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 22.29
Global response to chemotherapy-induced apoptosis 22.18
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 22.1
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 21.52
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 21.19
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 21.14
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 20.98
Splicing and epigenetic factors jointly regulate epidermal differentiation 20.91
Efficient and quantitative high-throughput tRNA sequencing 20.8
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 20.72
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 20.6
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 20.46
Effect of mitochondria deficiency on senescence-associated gene expression 20.45
Gene induction by the USP6 oncogene in response to interferon 20.39
Differential analysis of gene regulation at transcript resolution by RNA-Seq 20.06
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 20.06
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 20.05
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 19.99
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 19.99
MEIS1 regulates hematopoiesis in hPSCs 19.82
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 19.8
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 19.77
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 19.61
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 19.6
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 19.6
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 19.57
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 19.53
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 19.44
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 19.44
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 19.44
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 19.19
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 18.85
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 18.74
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 18.59
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 18.57
A code of mono-phosphorylation modulates the function of RB. 18.56
Differetially expressed genes after hTR overexpression in U2OS cells 18.53
RNA-seq differential expression studies: more sequence, or more replication? 18.5
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 18.43
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 18.35
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 18.33
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 18.3
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 18.3
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 18.14
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 18.13
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 18.1
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 18.1
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 17.79
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 17.69
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 17.56
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 17.56
Energy Metabolism during Anchorage-Independence 17.55
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 17.39
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 17.36
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 17.26
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 17.21
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 17.18
Genes significantly down or Up-regulated upon RNF219 knockdown 17.14
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 17.13
Retinoic acid suppresses MYB in adenoid cystic carcinoma 17.13
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 17.11
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 17.1
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 16.93
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 16.73
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 16.62
DRB/GRO-Seq -/+ UV 16.53
Paxillin regulates genomic networks in prostate cancer [PC3] 16.52
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 16.52
Reassessment of Exosome Composition 16.52
Transcriptional effect of ETV1 knockdown in melanoma cells 16.51
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 16.28
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 16.19
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 16.14
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 16.06
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 15.91
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 15.91
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 15.7
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 15.7
A role for ZNF598 in post-transcriptional gene regulation 15.63
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 15.54
Integrin signaling regulates YAP/TAZ to control skin homeostasis 15.5
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 15.45
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 15.45
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 15.38
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 15.38
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 15.18
Short and Long RNA sequencing of human mature erythrocytes 15.14
MYCi361 regulates MYC target genes 15.01
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 14.97
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 14.77
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 14.62
RNA sequencing of primary human platelets and in vitro cell lines 14.51
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 14.48
The regulartory role of ZCCHC24 in splicing machinery 14.43
Ribosomal footprinting of CN34-Parental and CN34-LM1a 14.4
Effect of CHKA knockdown on C4-2 cell transcriptome 14.34
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 14.29
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 14.29
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 14.24
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 14.23
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 14.17
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 14.04
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 13.95
High-throughput sequencing of pluripotent cells 13.83
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 13.75
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 13.69
Ribosomal footprinting of MDA-Parental and MDA-LM2 13.67
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 13.64
Spliceosomal disruption of the non-canonical BAF complex in cancer 13.56
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 13.49
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 13.42
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 13.39
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 13.31
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 13.29
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 13.0
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 13.0
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 12.92
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 12.92
R430: A potent inbibitor of DNA and RNA viruses 12.84
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 12.77
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 12.77
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 12.74
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 12.7
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 12.7
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 12.66
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 12.66
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 12.55
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 12.55
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 12.45
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 12.42
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 12.39
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 12.37
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 12.33
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 12.31
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 12.3
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 12.27
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 12.25
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 12.19
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 12.13
Characterization of the Merkel cell carcinoma miRNome 12.05
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 11.98
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 11.89
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 11.89
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 11.86
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 11.84
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 11.8
BET bromodomain inhibition 11.8
Role of microRNAs in the interaction between Salmonella and the host cell 11.78
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 11.76
Paxillin regulates genomic networks in prostate cancer [LNCaP] 11.71
RNA Sequencing of three pairs of gastric cancer 11.6
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 11.54
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 11.54
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 11.52
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 11.51
Solid phase chemistry to covalently and reversibly capture thiolated RNA 11.3
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 11.28
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 11.1
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 11.1
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 11.06
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 11.01
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 11.01
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 11.01
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 10.98
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 10.98
SRSF1 role in cellular gene expression and splicing 10.86
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 10.85
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 10.76
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 10.73
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 10.72
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 10.62
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 10.6
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 10.59
Human T-cell lymphoblastic lymphoma samples and control thymuses 10.59
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 10.54
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 10.47
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 10.45
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 10.45
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 10.34
Next generation sequencing of small RNAs isolated from exosomes in human semen 10.32
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 10.17
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 10.15
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 10.11
An optimization system for isolating and sequencing of single human colon cancer cells 10.06
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 10.04
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.02
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 10.01
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 9.98
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 9.94
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 9.78
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 9.78
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 9.7
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 9.7
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 9.61
Fbxo32 mediated gene expression program underlies EMT and metastasis 9.59
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 9.55
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 9.38
MCF-7 as a model for functional analysis of breast cancer risk variants 9.29
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 9.21
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 9.07
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 9.06
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 9.05
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 9.02
RNA polymerase in pre-B-ALL cell lines 8.93
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.87
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 8.86
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 8.82
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 8.71
Hypoxic transcriptome of SQ20B human head and neck cancer cells 8.7
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 8.56
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 8.48
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 8.48
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 8.39
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 8.39
Gene expression profiling in metabolically heterogeneous human lung tumors 8.1
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 8.09
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 7.98
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 7.96
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 7.95
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 7.95
RNA seq with AML (NB4) cells upon FTO inhibition 7.95
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.89
RNA-seq analysis of BAP1-depleted uveal melanoma cells 7.88
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 7.81
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 7.69
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 7.64
Comprehensive comparative analysis of 5’ end RNA sequencing methods 7.61
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 7.59
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 7.59
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 7.58
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 7.58
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 7.43
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 7.35
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 7.28
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 7.19
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 7.01
Human islets of varying quality: the good, the (not so) bad and the ugly 6.92
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 6.82
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 6.82
p53 activity results in DNA replication fork processivity 6.77
RNA transcriptome analysis during HSV-1 infection 6.74
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 6.74
Dysregulated immune system networks in war veterans with PTSD 6.73
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 6.7
snRNAs as regulators of alternative splicing 6.59
Widespread intronic polyadenylation diversifies immune cell transcriptomes 6.54
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 6.51
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 6.47
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 6.44
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.44
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 6.41
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 6.33
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 6.22
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 6.17
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 6.17
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.04
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 5.96
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.94
Transcriptome sequencing of K-562 cells 5.89
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 5.83
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 5.77
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 5.77
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.75
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 5.69
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.56
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 5.55
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 5.55
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 5.53
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 5.5
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 5.42
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 5.37
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 5.37
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 5.34
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 5.28
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 5.23
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.22
Leucegene: AML sequencing (part 6) 5.16
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 5.15
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.09
Transcription elongation regulates genome 3D structure 5.03
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.98
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.98
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.91
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.84
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 4.8
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 4.78
Transcriptome of diurnal human blood neutrophils 4.74
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.72
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 4.64
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 4.47
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 4.45
RNA Sequencing of Human iPS derived Cardiomyocytes 4.45
6mer seed toxicity in tumour suppressive microRNAs 4.42
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 4.35
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 4.29
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 4.29
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 4.27
Clinker: visualizing fusion genes detected in RNA-seq data 4.2
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.15
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 4.1
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 4.1
Glucose inhibits cardiac maturation through nucleotide biosynthesis 4.06
Global transcriptome analysis of WT versus HEB-/- hESCs 4.03
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.01
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.91
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.9
TAF1 is critical for AE driven leukemogenesis 3.9
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 3.86
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.83
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.83
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 3.83
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 3.75
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.58
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.44
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.42
CDK12 mediated transcriptional regulation in U2OS cells 3.41
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.41
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.33
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 3.33
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 3.33
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 3.25
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 3.23
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.17
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.17
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.96
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.9
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 2.86
Regulation of poly(A) tail and translation during the somatic cell cycle 2.81
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 2.71
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 2.69
Genome-wide Analysis of Chromatin Interactions in Human Cells 2.49
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.47
LncRNA expression profiling of ischemic stroke patients 2.34
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 2.31
HEXIM1 is induced by DHODH inhibition to suppress melanoma 2.31
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.3
Total RNA-Seq data from leukemic patients with complex structural variants 2.23
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.17
Positively selected enhancer elements endow tumor cells with metastatic competence 2.13
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.05
Identification of a LIF-responsive replication-competent human β cell 1.97
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.95
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.87
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 1.86
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 1.86
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.81
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 1.77
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 1.67
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.66
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.59
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.48
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 1.45
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 1.45
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.39
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.39
Identification of long noncoding RNAs in T-ALL cell lines 1.37
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 1.23
iPSC derived motor neuron cultures from C9ORF72 carriers 1.22
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.14
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.14
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.05
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.99
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.96
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.93
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.77
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.76
Transcriptome Profiling of Human Primary Monocytes 0.72
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.72
Ribosome profiling upon inhibition of eIF4A 0.72
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 0.67
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.63
Leucegene: ALL sequencing 0.63
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.6
MHC Transcriptomic landscape at haplotype-specific resolution 0.59
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.53
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.53
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.53
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 0.46
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.36
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.11
Measure transcript integrity using RNA-seq data 0.11
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.09
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.09
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.09
mRNA recovered upon RNF219 IP. [RNA-IP] 0.06
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.05
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.02
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation